We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock

Delisted

KRTX was delisted on the 15th of March, 2024.

159 hedge funds and large institutions have $3.13B invested in Karuna Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

44% more call options, than puts

Call options by funds: $9.5M | Put options by funds: $6.61M

36% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 47

7% more capital invested

Capital invested by funds: $2.93B → $3.13B (+$204M)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding

Funds holding: 159159 (0)

Holders
159
Holders Change
Holders Change %
0%
% of All Funds
2.78%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
13
Increased
64
Reduced
47
Closed
12
Calls
$9.5M
Puts
$6.61M
Net Calls
+$2.9M
Net Calls Change
+$6.86M
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$5.57M +$439K +3,800 +9%
AllianceBernstein
52
AllianceBernstein
Tennessee
$5.42M -$246K -2,130 -5%
Neuberger Berman Group
53
Neuberger Berman Group
New York
$4.92M +$672K +5,821 +16%
TD Asset Management
54
TD Asset Management
Ontario, Canada
$4.88M +$219K +1,900 +5%
HNB
55
Huntington National Bank
Ohio
$4.67M
AA
56
ALPS Advisors
Colorado
$4.43M -$286K -2,478 -6%
First Manhattan
57
First Manhattan
New York
$3.93M
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$3.53M -$200K -1,734 -6%
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$3.51M
FAM
60
Fred Alger Management
New York
$3.43M +$47.2K +409 +1%
OIA
61
OneDigital Investment Advisors
Kansas
$3.31M
Rafferty Asset Management
62
Rafferty Asset Management
New York
$3.2M +$806K +6,986 +36%
State of New Jersey Common Pension Fund D
63
State of New Jersey Common Pension Fund D
New Jersey
$3.18M +$473K +4,099 +19%
EP
64
Eversept Partners
New York
$3.06M +$2.89M +25,000 New
Bank of America
65
Bank of America
North Carolina
$3.02M +$15.7K +136 +0.6%
UBS Group
66
UBS Group
Switzerland
$2.9M +$2.67M +23,096 +3,780%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$2.77M +$62.2K +539 +2%
Millennium Management
68
Millennium Management
New York
$2.73M +$2.58M +22,348 New
Citigroup
69
Citigroup
New York
$2.72M -$1.41M -12,212 -35%
Allianz Asset Management
70
Allianz Asset Management
Germany
$2.36M +$3.12K +27 +0.1%
Barclays
71
Barclays
United Kingdom
$2.32M +$182K +1,580 +9%
Legal & General Group
72
Legal & General Group
United Kingdom
$2.21M +$461K +3,993 +28%
CPW
73
Catalyst Private Wealth
California
$2.2M +$577K +5,000 +38%
D.E. Shaw & Co
74
D.E. Shaw & Co
New York
$1.99M -$111K -964 -6%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$1.97M -$358K -3,101 -16%

KRTX Hedge Fund Activity: Q3 2021 in Review

159 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q3 2021, worth a combined $3.13B — up 7% from $2.93B a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new KRTX positions and 12 closed out — a net gain of 1 holder — while 64 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.7M. The largest seller was Sands Capital Management, exiting entirely with an estimated $43.4M sold.

  • 159 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $3.13B of Karuna Therapeutics, Inc. Common Stock stock for Q3 2021, up 7% quarter-over-quarter.
  • 13 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q3 2021 and 12 closed out, a net change of +1 holder.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q3 2021 was State Street, an estimated $15.7M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q3 2021 was Sands Capital Management, an estimated $43.4M sold.

Based on aggregated 13F filings for Q3 2021.